Value of increased CRP/albumin ratio in predicting embolic events in patients with infective endocarditis

Şaban Kelesoglu1, Sinan Inci2, Murat Gul2

  • 1Department of Cardiology, Erciyes University Faculty of Medicine, Kayseri, Türkiye.

Biomarkers in Medicine
|October 9, 2023
PubMed

Insights

The CRP/albumin ratio (CAR), an inflammatory marker, effectively predicts embolic events in infective endocarditis patients. Higher CAR levels indicate a greater risk of these dangerous complications.

Area of Science:

  • Cardiology
  • Inflammation markers

Background:

  • The CRP/albumin ratio (CAR) is an emerging inflammatory marker linked to adverse outcomes in cardiovascular diseases.
  • Its predictive value for embolic events in infective endocarditis (IE) requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of the CAR in predicting embolic events in patients diagnosed with IE.
  • To determine if CAR is an independent predictor of embolic events in this population.

Main Methods:

  • Retrospective analysis of clinical, laboratory, and echocardiographic data from 145 IE patients.
  • Patients were divided into two groups based on the presence or absence of embolic events.
  • Multivariate analysis was employed to identify independent predictors.

Main Results:

  • Patients with embolic events exhibited significantly higher CRP and CAR values compared to those without.
  • A high CAR value (OR: 1.030; 95% CI: 1.000-1.060; p=0.041) was identified as an independent predictor of embolic events.
  • CRP levels were also significantly elevated in patients with embolic events (p < 0.001).

Conclusions:

  • The CAR is a valuable, accessible, and cost-effective marker for predicting embolic events in IE patients.
  • Elevated CAR levels are associated with an increased risk of embolic complications in infective endocarditis.
  • This finding supports the clinical utility of CAR in managing IE patients.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
101
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
11
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
22
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
177
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
9